Centros de Estudos Farmacêuticos, Universidade de Coimbra, Coimbra, Portugal.
J Med Food. 2010 Jun;13(3):681-90. doi: 10.1089/jmf.2009.0115.
Cymbopogon citratus, an herb known worldwide as lemongrass, is widely consumed as an aromatic drink, and its fresh and dried leaves are currently used in traditional cuisine. However, little is known about the mechanism of action of C. citratus, namely, the anti-inflammatory effects of its dietary components. Because nitric oxide (NO), produced in large quantities by activated inflammatory cells, has been demonstrated to be involved in the pathogenesis of acute and chronic inflammation, we evaluated the effects of the infusion of dried leaves from C. citratus, as well as its polyphenolic fractions--flavonoid-, tannin-, and phenolic acid-rich fractions (FF, TF, and PAF, respectively)--on the NO production induced by lipopolysaccharide (LPS) in a skin-derived dendritic cell line (FSDC). C. citratus infusion significantly inhibited the LPS-induced NO production and inducible NO synthase (iNOS) protein expression. All the polyphenolic fractions tested also reduced the iNOS protein levels and NO production stimulated by LPS in FSDC cells, without affecting cell viability, with the strongest effects being observed for the fractions with mono- and polymeric flavonoids (FF and TF, respectively). Our results also indicated that the anti-inflammatory properties of FF are mainly due to luteolin glycosides. In conclusion, C. citratus has NO scavenging activity and inhibits iNOS expression and should be explored for the treatment of inflammatory diseases, in particular of the gastrointestinal tract.
香茅草,又名柠檬草,是一种在世界范围内广受欢迎的草本植物,常被用作芳香饮料,其新鲜和干燥的叶子目前被用于传统烹饪。然而,人们对香茅草的作用机制知之甚少,即其食用成分的抗炎作用。由于大量由激活的炎症细胞产生的一氧化氮(NO)已被证明参与了急慢性炎症的发病机制,我们评估了香茅草干叶的浸液,以及其多酚类化合物 - 富含类黄酮、单宁和酚酸的部分(FF、TF 和 PAF 分别) - 对脂多糖(LPS)诱导的皮肤衍生树突状细胞系(FSDC)中 NO 产生的影响。香茅草浸液可显著抑制 LPS 诱导的 NO 产生和诱导型一氧化氮合酶(iNOS)蛋白表达。所有测试的多酚类化合物也可降低 LPS 刺激的 FSDC 细胞中 iNOS 蛋白水平和 NO 产生,而不影响细胞活力,其中具有单和聚合类黄酮的部分(FF 和 TF)作用最强。我们的结果还表明,FF 的抗炎特性主要归因于叶黄素糖苷。总之,香茅草具有清除 NO 的活性,并抑制 iNOS 的表达,应探索用于治疗炎症性疾病,特别是胃肠道疾病。